Skip to main content

Premium Project

Board Round Effectiveness Audit

Audit whether board rounds are structured, multidisciplinary, action-focused and effective in identifying patient status, discharge barriers, criteria to reside, escalation needs and clear next steps.

PremiumNew
Explore Catalogue

Overview

This project audits whether board rounds reliably support patient flow, safe care coordination and timely decision-making. It reviews whether a board round is held with the expected multidisciplinary attendance and a structured format, whether every patient is reviewed with clinical status, criteria to reside and expected discharge date considered, whether discharge barriers are identified with owned actions and timescales, whether therapy, pharmacy, equipment, social care and community referrals are requested where indicated, and whether escalation, documentation, follow-up of previous actions and communication with the wider team, patient or carers are completed.

Specialties, services & categories

Clinical specialties:Acute MedicineEmergency MedicineGeneral Internal MedicineGeriatric MedicineFrailtyRespiratory MedicineCardiologyGastroenterologyStroke MedicineRehabilitationSurgeryTrauma and OrthopaedicsOrthogeriatricsPalliative Medicine
Healthcare services:Nursing & AHPsPharmacyClinical Governance
Categories:Patient Flow & Operational ImprovementGovernancePatient Safety

Who should use it

  • Ward leadership teams, nurses in charge and ward managers
  • Acute medicine, general internal medicine, geriatric medicine and frailty teams
  • Pharmacists, physiotherapists, occupational therapists and discharge coordinators
  • Site management, patient-flow and clinical operations teams
  • QI leads, governance teams and educators

Objectives

  • Measure whether board rounds are held with the expected structure and multidisciplinary input
  • Assess patient-level review, criteria to reside and expected discharge date documentation
  • Review whether discharge barriers generate owned actions with timescales and escalation
  • Identify variation in documentation, follow-up and communication across clinical areas
  • Generate governance-ready and ARCP-ready evidence

Data collected

  • Anonymous case or board-round identifier
  • Inclusion / eligibility decision
  • Anonymised case context (clinical setting, board round timing, disciplines present, review context, age band)
  • Clinical area / location and optional specialty / service
  • Sixteen board round effectiveness criteria (met / not met / not applicable)
  • Free-text learning points and any project custom fields

Outputs generated

  • Live dashboard
  • Audit report (Word)
  • Executive summary (Word)
  • Excel workbook
  • PowerPoint presentation
  • Conference poster
  • ARCP evidence summary

Standards and guidance

This ready-built project is developed using the guidance, standards and authoritative sources listed below, so you can see what is being measured and why. Lazomis QI does not publish or own this guidance, and inclusion here does not imply endorsement or approval by any of these organisations.

Governance notes

  • Designed to use anonymised or pseudonymised audit identifiers.
  • This tool supports, but does not replace, clinical judgement.
  • Local policy, formulary and specialist advice should be followed.
  • Organisations remain responsible for local governance arrangements.
  • This tool supports, but does not replace, clinical judgement. Follow local board round, patient-flow and escalation policy.
  • Board round frequency, timing thresholds and attendance expectations remain locally configurable and are not national standards.
  • Use anonymous case identifiers only — never patient-identifiable information.

Lazomis QI supporting resources

Supporting guidance from the Lazomis QI Resource Library. Authoritative clinical standards referenced by this project remain separate.